- Home
- RNXT vs CNF Comparison
RNXT vs CNF Comparison
Compare RNXT & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- CNF
- Stock Information
- Founded
- RNXT 2012
- CNF 1999
- Country
- RNXT United States
- CNF China
- Employees
- RNXT N/A
- CNF N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- CNF Finance: Consumer Services
- Sector
- RNXT Health Care
- CNF Finance
- Exchange
- RNXT Nasdaq
- CNF Nasdaq
- Market Cap
- RNXT 44.0M
- CNF 35.7M
- IPO Year
- RNXT 2021
- CNF 2018
- Fundamental
- Price
- RNXT $1.12
- CNF $4.72
- Analyst Decision
- RNXT Strong Buy
- CNF
- Analyst Count
- RNXT 2
- CNF 0
- Target Price
- RNXT $7.50
- CNF N/A
- AVG Volume (30 Days)
- RNXT 579.1K
- CNF 27.2K
- Earning Date
- RNXT 11-13-2025
- CNF 08-28-2025
- Dividend Yield
- RNXT N/A
- CNF N/A
- EPS Growth
- RNXT N/A
- CNF N/A
- EPS
- RNXT N/A
- CNF N/A
- Revenue
- RNXT $662,000.00
- CNF $50,241,013.00
- Revenue This Year
- RNXT $2,895.35
- CNF $252.34
- Revenue Next Year
- RNXT $313.04
- CNF N/A
- P/E Ratio
- RNXT N/A
- CNF N/A
- Revenue Growth
- RNXT N/A
- CNF N/A
- 52 Week Low
- RNXT $0.75
- CNF $2.36
- 52 Week High
- RNXT $1.69
- CNF $15.44
- Technical
- Relative Strength Index (RSI)
- RNXT 45.33
- CNF 53.16
- Support Level
- RNXT $1.12
- CNF $4.34
- Resistance Level
- RNXT $1.15
- CNF $4.96
- Average True Range (ATR)
- RNXT 0.07
- CNF 0.45
- MACD
- RNXT -0.01
- CNF -0.07
- Stochastic Oscillator
- RNXT 28.00
- CNF 66.87
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.